Methoxetamine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==General Information== | ==General Information== | ||
Methoxamine is a near chemical analogue of Ketamine and PCP. It was first publicly reported in 2010. Some say it's similar to Ketamine or a high dose DXM. It has been shown to act as an NMDA receptor antagonist and Serotonin | Methoxamine (3-MeO-2-Oxo-PCE) is a near chemical analogue of Ketamine and PCP. It was first publicly reported in 2010. Some say it's similar to Ketamine or a high dose DXM. It has been shown to act as an NMDA receptor antagonist and Serotonin Reuptake Inhibitor. The N-Ethyl group on this compound increases potency. | ||
==Dosage== | ==Dosage== | ||
Oral | Oral | ||
* Threshold 5-20mg | * Threshold 5-20mg | ||
* Low 10-30mg | * Low 10-30mg | ||
* Common 40-60mg | * Common 40-60mg | ||
* Strong 50-100mg | * Strong 50-100mg+ | ||
Insufflated | Insufflated | ||
* Threshold 5-15mg | * Threshold 5-15mg | ||
* Low 15-30mg | * Low 15-30mg | ||
* Medium 30-50mg | * Medium 30-50mg | ||
* Strong 50-75mg | * Strong 50-75mg | ||
* Hole 75-100mg | * Hole 75-100mg+ | ||
Sublingual | Sublingual | ||
* Threshold 5-10mg | * Threshold 5-10mg | ||
* Low 10-25mg | * Low 10-25mg | ||
* Medium 40-60mg | * Medium 40-60mg | ||
* Strong 60-75mg | * Strong 60-75mg | ||
* Hole 75-100mg | * Hole 75-100mg | ||
==Harm Reduction== | ==Harm Reduction== | ||
* Avoid driving at all costs | * Avoid driving at all costs. | ||
* Avoid walking or moving around in general if you are on a medium to hole dose. | * Avoid walking or moving around in general if you are on a medium to hole dose. | ||
* Taking this on a non-empty substance could lead to nausea. | * Taking this on a non-empty substance could lead to nausea. | ||
[[Category:Drugs]] [[Category:Dissociative]] | [[Category:Drugs]] | ||
[[Category:Dissociative]] | |||
Revision as of 07:01, 17 March 2014
General Information
Methoxamine (3-MeO-2-Oxo-PCE) is a near chemical analogue of Ketamine and PCP. It was first publicly reported in 2010. Some say it's similar to Ketamine or a high dose DXM. It has been shown to act as an NMDA receptor antagonist and Serotonin Reuptake Inhibitor. The N-Ethyl group on this compound increases potency.
Dosage
Oral
- Threshold 5-20mg
- Low 10-30mg
- Common 40-60mg
- Strong 50-100mg+
Insufflated
- Threshold 5-15mg
- Low 15-30mg
- Medium 30-50mg
- Strong 50-75mg
- Hole 75-100mg+
Sublingual
- Threshold 5-10mg
- Low 10-25mg
- Medium 40-60mg
- Strong 60-75mg
- Hole 75-100mg
Harm Reduction
- Avoid driving at all costs.
- Avoid walking or moving around in general if you are on a medium to hole dose.
- Taking this on a non-empty substance could lead to nausea.